Stat News: Safety-net hospitals take big markups on cancer drugs for commercially insured patients, study finds
By Ed Silverman
September 15th, 2021
Hospitals participating in a federal drug discount program marked up cancer medicines four times for privately insured patients, and often charged cash-paying consumers the same as commercial insurers, a practice that does not “fit the mission” of serving low-income populations, a new analysis found.
